IRD
Opus Genetics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.67
+1.52%Leverage
- Debt / equity
- -2.69x
- Net debt / equity
- 4.15x
- Debt / assets
- 0.38x
- Debt / EBITDA
- -0.33x
- Net debt / EBITDA
- 0.51x
Liquidity & coverage
- Current ratio
- 12.19x
- Quick ratio
- 12.19x
- Cash ratio
- 11.68x
- Interest coverage
- -19.11x
- EBITDA / interest
- -39.62x
- Working capital
- $85.1M
Cash & dividend
- FCF / debt
- -1.16x
- Cash flow / debt
- -1.16x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026